Auspogen Injection 300ug

About Auspogen Injection 300ug

Auspogen Injection 300ug Uses

• Chemotherapy induced neutropenia in cancer patients
• Low white blood cell counts after bone marrow transplant
• Severe chronic neutropenia in adults and children
• Prevention of infections during cancer treatment
• Stem cell mobilization before bone marrow transplant

Auspogen Injection 300ug Benefits

• Faster recovery of neutrophil counts after chemotherapy
• Lower risk of serious infections during cancer treatment
• Support for uninterrupted chemotherapy schedules
• Effective option for bone marrow transplant recovery
• Trusted growth factor therapy used in major hospitals

Cancer treatment centers in Lahore, Karachi, Islamabad, and Rawalpindi rely on Auspogen Injection 300ug for patients with low white blood cell counts. Oncologists in these cities prescribe it during chemotherapy cycles to lower infection risk.

This injection stimulates bone marrow to produce more neutrophils, a type of white blood cell. It plays a key role in supporting immunity during intensive cancer treatment.

This is a specialist administered biologic, not a self care option. A hematologist or oncologist must supervise every dose and monitor blood counts closely.

Drug Class

• Granulocyte colony stimulating factor (G CSF)
• Hematopoietic growth factor
• Recombinant biologic therapy

Auspogen Injection 300ug formula

• Filgrastim

Available forms

• Injection

How to use Auspogen Injection 300ug?

• Administration by a trained healthcare provider through subcutaneous or intravenous injection.
• Dosage based on body weight and blood count levels, as calculated by the oncologist.
• Regular blood tests during treatment to track white blood cell recovery.
• Storage in a refrigerator until the moment of use, avoiding freezing.
• Reporting of bone pain or fever to the treating doctor without delay.

Drug Interactions

Few significant interactions exist with Auspogen Injection 300ug, though timing around cancer treatment matters. Doctors carefully plan the injection schedule around other therapies.

• Chemotherapy Drugs: Administration is avoided within 24 hours before or after chemotherapy doses.
• Radiation Therapy: Combined use requires careful timing to avoid reduced effectiveness.
• Lithium: Possible enhancement of neutrophil release, needing closer monitoring by the doctor.

Risks and warnings

• Splenic Rupture: Rare but serious risk, with left upper abdominal or shoulder pain as a warning sign.
• Allergic Reactions: Severe hypersensitivity possible, including rash, swelling, and breathing difficulty.
• Sickle Cell Disease: Higher risk of sickle cell crisis in patients with this condition.
• Lung Complications: Acute respiratory distress syndrome reported in rare cases.
• Blood Count Monitoring: Regular complete blood counts necessary throughout treatment.

Side Effects

Bone pain is the most common effect of this injection. Most side effects are manageable and temporary.

• Bone or joint pain
• Headache
• Low grade fever
• Nausea or mild stomach upset
• Fatigue or general weakness

Serious side effects are uncommon but require urgent medical care. Emergency attention is necessary if any of these develop.

• Severe abdominal or shoulder pain suggesting splenic rupture
• Difficulty breathing or chest pain
• Signs of severe allergic reaction
• Blood in urine or decreased urination

Storage Conditions

Store in a refrigerator between 2°C and 8°C without freezing. Protect from light and discard if the solution looks cloudy or discolored.